Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter F Rebeiro

Showing results (41-50 of 150) with videos related to

Pageof 15
Sort By:
Medrxiv : the Preprint Server for Health Sciences|November 18, 2021
Minimal in-school SARS-CoV-2 transmission with strict mitigation protocols at two independent schools in Nashville, TNLauren S Peetluk, Peter F Rebeiro, Kathryn M Edwards, et al.
Epidemiology (Cambridge, Mass.)|June 30, 2010
Estimating the optimal CD4 count for HIV-infected persons to start antiretroviral therapyBryan E Shepherd, Cathy A Jenkins, Peter F Rebeiro, et al.
AIDS Research and Human Retroviruses|May 3, 2017
Trends in HIV Continuum of Care Outcomes over Ten Years of Follow-Up at a Large HIV Primary Medical Home in the Southeastern United StatesMichael K Ghiam, Peter F Rebeiro, Megan Turner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2018
Impact of Culture-Independent Diagnostic Testing on Recovery of Enteric Bacterial InfectionsAamer Imdad, Fiona Retzer, Linda S Thomas, et al.
Plos One|January 4, 2013
Virologic, immunologic and clinical responses in foreign-born versus US-born HIV-1 infected adults initiating antiretroviral therapy: an observational cohort studyDeidra D Parrish, Meridith Blevins, Samuel E Stinnette, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 30, 2010
Race, kidney disease progression, and mortality risk in HIV-infected personsTahira P Alves, Todd Hulgan, Pingsheng Wu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 13, 2017
Observational Study of the Effect of Patient Outreach on Return to Care: The Earlier the BetterPeter F Rebeiro, Giorgos Bakoyannis, Beverly S Musick, et al.
Public Health Reports (Washington, D.C. : 1974)|January 27, 2017
The 2013 HIV Continuum of Care in Tennessee: Progress Made, but Disparities PersistCarolyn Wester, Peter F Rebeiro, Thomas J Shavor, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 23, 2011
Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?April C Pettit, Cathy A Jenkins, Samuel E Stinnette, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2008
Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing proceduresPeter F Rebeiro, Asghar Kheshti, Sally S Bebawy, et al.
Pageof 15

Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
Medrxiv : the Preprint Server for Health Sciences|November 18, 2021
Minimal in-school SARS-CoV-2 transmission with strict mitigation protocols at two independent schools in Nashville, TNLauren S Peetluk, Peter F Rebeiro, Kathryn M Edwards, et al.
Epidemiology (Cambridge, Mass.)|June 30, 2010
Estimating the optimal CD4 count for HIV-infected persons to start antiretroviral therapyBryan E Shepherd, Cathy A Jenkins, Peter F Rebeiro, et al.
AIDS Research and Human Retroviruses|May 3, 2017
Trends in HIV Continuum of Care Outcomes over Ten Years of Follow-Up at a Large HIV Primary Medical Home in the Southeastern United StatesMichael K Ghiam, Peter F Rebeiro, Megan Turner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2018
Impact of Culture-Independent Diagnostic Testing on Recovery of Enteric Bacterial InfectionsAamer Imdad, Fiona Retzer, Linda S Thomas, et al.
Plos One|January 4, 2013
Virologic, immunologic and clinical responses in foreign-born versus US-born HIV-1 infected adults initiating antiretroviral therapy: an observational cohort studyDeidra D Parrish, Meridith Blevins, Samuel E Stinnette, et al.
Clinical Journal of the American Society of Nephrology : CJASN|September 30, 2010
Race, kidney disease progression, and mortality risk in HIV-infected personsTahira P Alves, Todd Hulgan, Pingsheng Wu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 13, 2017
Observational Study of the Effect of Patient Outreach on Return to Care: The Earlier the BetterPeter F Rebeiro, Giorgos Bakoyannis, Beverly S Musick, et al.
Public Health Reports (Washington, D.C. : 1974)|January 27, 2017
The 2013 HIV Continuum of Care in Tennessee: Progress Made, but Disparities PersistCarolyn Wester, Peter F Rebeiro, Thomas J Shavor, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 23, 2011
Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?April C Pettit, Cathy A Jenkins, Samuel E Stinnette, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 17, 2008
Increased detectability of plasma HIV-1 RNA after introduction of a new assay and altered specimen-processing proceduresPeter F Rebeiro, Asghar Kheshti, Sally S Bebawy, et al.
Pageof 15